Effect of FR104, a Novel Anti-CD28 Fab, in Monkey Cardiac Allograft Transplantation.Zhang · Transplantation2014PDF238 KB
Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ AntibodyPoirier · American Journal of Transplantation2012PDF1008 KB
Fr104 ASSOCIATION OF GASTROINTESTINAL SYMPTOMS WITH OUTCOMES IN COVID-19 HOSPITALIZATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS.Mehta · Gastroenterology2021PDF1.1 MB
Preclinical Evaluation of FR104, An Antagonist Anti-CD28 Monovalent Fabʼantibody, in DTH and Kidney Transplant Primates ModelsPoirier · Transplantation2012PDF805 KB
First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28Poirier · The Journal of Immunology2016PDF1.4 MB
Preclinical Efficacy and Immunological Safety of FR104, An Antagonist Anti-CD28 Monovalent Fabʼantibody, in Humanized Mice ModelsPoirier · Transplantation2012PDF821 KB
FR104, an Antagonist Anti-CD28 Monovalent Fab’ Antibody, Prevents Alloimmunization and Allows Calcineurin Inhibitor Minimization in Nonhuman Primate Renal AllograftPoirier · American Journal of Transplantation2014PDF1.6 MB
Evaluation of FR104, a Treg Sparing Antagonist anti-CD28 Monovalent Fab’ Antibody in Kidney Transplantation in Non-human PrimatesPoirier et al. · BioMed Central2012PDF84 KB
